A THREE-PERIOD STUDY TO INVESTIGATE THE RELATIVE BIOAVAILABILITY AND PHARMACODYNAMIC PROFILES OF A ZEGERID 20MG CAPSULE, ZEGERID 20MG POWDER FOR ORAL SUSPENSION AND LOSEC 20MG CAPSULE IN HEALTHY ADULT VOLUNTEERS UNDER FASTING CONDITIONS: